RxDoctor Payments Data

Kimberly Vilt, APRN

Psychiatric/Mental Health · Louisville, KYNPI 1083206742

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,540 and has fallen 90.9% since, to $230 in 2025. Among psychiatric/mental health clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,668in general payments, 2019–2025

Across 403 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$543
  • Lundbeck LLC$543
  • Bausch Health US, LLC$469
  • Teva Pharmaceuticals USA, Inc.$461
  • Otsuka America Pharmaceutical, Inc.$455
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$6,62199%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,668 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,405
Medicare patients
14
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl32$849
Bupropion XlBupropion Hcl17$502
Quetiapine Fumarate19$439
Lamotrigine27$417
Trazodone Hcl39$328
Gabapentin21$225
Escitalopram Oxalate23$206
Alprazolam17$116
Fluoxetine Hcl11$85

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →